from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3654c/-

LFCtreatmentdescriptionclass of inhibitor

0.787

Amikacinug/mL Amikacintranslation

-0.352

Cap5-10ug/mL Capreomycintranslation

-0.200

Rox10-50 ug/mL Roxithromycintranslation

-0.256

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.958

Rif0.2-5ug/mL Rifampicintranscription

0.102

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.517

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.139

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.451

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.136

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.045

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.547

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.223

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.591

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.139

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.001

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.753

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.472

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.447

KCN5-20 ug/mL Potassium cyaniderespiration

-1.557

NaN30.2-2 mM Sodium aziderespiration

-0.861

Nigericin50 uM Nigericinrespiration

0.572

TRC10-150 ug/mL Triclosanrespiration

-1.001

TRZ10-25 ug/mL Thioridazinerespiration

0.507

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.145

menadione6-10 ug/mL Menadionerespiration

0.684

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.345

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.323

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.332

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.995

NRP_1Non-replicating persistence stage 1dosRassociated

-0.463

Amp0.2mg/mL AmpicillincellWall

-0.175

Cephalexin20-100 ug/mL CephalexincellWall

0.137

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.185

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.090

EMB10-20 ug/mL EthambutolcellWall

-0.307

Eta12-40 ug/mL EthionamidecellWall

-0.649

INH0.2-0.4 ug/mL IsoniazidcellWall

0.120

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.399

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.201

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.400

BZA0.12 mg/mL BenzamidearomaticAmides

-0.274

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.287

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.074

H2O24 mM hydrogen peroxideDNAdamaging

0.089

Levo10 ug/mL LevofloxacinDNAdamaging

0.332

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.032

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.377

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.221

UVUV-irradiationDNAdamaging

0.316

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.454

Antimycin12.5-50 ug/mL Antimycin A?

-1.101

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.119

PA_110-50 ug/mL Antitubercular compound PA-1?

0.820

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.699

PA8240.2-2 ug/mL PA-824?

-0.083

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.724

Verapamil50 uM Verapamil?

-0.018

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.750

methoxatin10-20 ug/mL Methoxatin?